Page 2 - Pharma Market

Pharma industry needs to focus on innovative products, says Mandaviya

The domestic pharmaceutical industry needs to focus on the research and development of innovative products in order to move up the value chain and achieve global leadership in the sector, Union minister Mansukh Mandaviya said on Tuesday. The Union health minister, who also helms the Chemical and Fertilisers ministry, asked the medical technology companies to produce critical equipment in India for the global markets. While formally unveiling the National Policy on Research & Development and Innovation in the Pharma-Med Tech Sector here, Mandavya said the domestic pharmaceutical companies invest less on research and development when compared to multinational companies. "International MNCs spend 20-25 per cent of their profits in research and innovation while for Indian companies the average is around 10 per cent...Till the time we do not come out with research-led innovative products, we cannot lead the segment globally," he noted. He said the government wants to make the pharma ...

Herbal pharma demand highlights traditional practices value: Mandaviya

Union Health Minister Mansukh Mandaviya on Thursday pitched for collective efforts by embracing ancient wisdom and modern science to achieve the health-related sustainable development goals. Inaugurating the WHO's first-ever Global Summit for Traditional Medicine here, the minister said it presents a unique platform for dialogue, idea exchange, collaboration, and international partnerships in the realm of traditional and complementary medicine. World Health Organization (WHO) Director-General Tedros Adhanom Ghebreyesus, Union Ayush Minister Sarbananda Sonowal and Gujarat Chief Minister Bhupendrabhai Patel were present at the inaugural event. Co-hosted by the Ministry of Ayush, the summit is a co-branded event as part of the ongoing G20 Health Ministers' meeting being held in Gandhinagar in Gujarat from August 17 to 19. Mandaviya said, "For centuries, traditional and complementary medicine has played a pivotal role in promoting personal and community health. Even in modern times, th

Fierce competition among new drug brands for share of India market

The competitive intensity is high between brands, at a time when volume growth in the domestic pharma market is on a slow lane

India finds 'violations' at cough syrup maker linked to Cameroon deaths

Authorities have stepped up scrutiny of drugmakers after some cough syrups made in India were linked to deaths of dozens of children overseas

Indian pharma market back to pre-Covid level in FY23, says report

After a Covid-hit FY21 (when the IPM grew by only 2.2 per cent), the market posted a growth of 14.7 per cent in FY22, on a low base

Chintan shivir on drugs to diagnose and treat issues of trust, quality

Proposals to be discussed at Hyderabad conclave include having a centralised drug registration system under CDSCO

Pharma marketing practices: High-level committee to meet industry on Friday

The UCPMP is voluntary and there is no legal penalty for violating the code

Centre defends Universal Code of Pharma Marketing Practices in apex court

The government further added that it is working on providing statutory backing to the UCPMP code and "it is a time-consuming process, which cannot be completed in haste"

Expensive deal valuations to hit Torrent Pharma's near-term earnings

Sales trajectory in domestic formulations and resolution of regulatory issues are other triggers

Govt forms 5-member committee to review pharma marketing practices

It will recommend 'legally enforceable mechanisms', is expected to give a report in 90 days

Dr Reddy's Laboratories eyes place among top five domestic pharma players

The US would continue to remain an important geography, but the firm says it hopes to double its revenues from China and grow revenues five-fold in Brazil in the next five years

Domestic branded generic formulations market can grow at 10-12%: Industry

Cadila Healthcare Chairman Pankaj Patel said the market can grow when there is overall growth

Strong growth rates expected to drive Abbott India's outperformance

New launches, power brands, digital initiatives to keep it ahead of peers

Active pharmaceutical ingredients sales momentum begins to normalise

With API supply, especially from China, facing some constraints because of lockdowns in several countries, demand from global clients had shot up for Indian players

Torrent Pharma Q2 net up 27% despite dip in US and Brazil revenues

Firm's consolidated total revenue for the quarter, however, fell marginally by 0.7% to stand at Rs 2,023 crore

Share of drugs under price control dips in domestic pharma market

India follows a market-based mechanism for determining ceiling prices of medicines that are a part of the National List of Essential Medicines (NLEM)

Domestic pharma market bounces back to growth phase in November

The Indian pharma market registered 14.5% YoY growth in November

Post-monsoon Indian pharma market growth slips to 5.1% in October

The drop in growth for the month of October 2019 has been seen across the therapies.

Seven of top 10 drug brands sold in India are from multinational companies

The top 10 corporates contribute to 43% of the domestic pharma market

Will close $150-mn funding in 3-5 months: Medlife CEO Ananth Narayanan

MedLife has seen 100 per cent year-on-year growth. It has built very unique assets that are not there with other players